Status:
COMPLETED
Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Somatization Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This study will examine the long-term effect of cognitive-affective behavior therapy on the physical symptoms, functioning, and health care utilization of people with somatization disorder.
Detailed Description
Somatization disorder is a syndrome characterized by the presence of multiple medically unexplained physical symptoms. It often results in substantial functional impairment and the need for extensive ...
Eligibility Criteria
Inclusion
- Meets DSM-IV criteria for somatization disorder
- Available for follow-up over the ensuing 18 months
- English-speaking
Exclusion
- Meets DSM-IV criteria for a psychotic disorder, organic brain syndrome, or psychoactive substance dependence (Other psychiatric comorbidity is not exclusionary)
- Active suicidal ideation
- Unstable major medical condition
- Plans to engage in additional psychotherapy during the first 6 months after enrollment
- Current use of any medication that has not been stabilized for the previous 2 months
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00149760
Start Date
August 1 2003
End Date
February 1 2010
Last Update
February 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, Robert Wood Johnson Medical School
Piscataway, New Jersey, United States, 08854